leisure time -WSS

leisure time

author：leisure time 2025-09-27 23:01:37 - browse：1372

Adam's take main illustration — Molly Ferguson/STAT

Roivant Sciences’ Matt Gline might be this year’s best biopharma CEO, and other thoughts about Monday’s blockbuster deal with Roche — like, why the heck did Roivant’s stock trade down?

Gline created $5 billion from $50 million — in less than one year.Regular readers know that every December, I choose a best biopharma CEO. It’s a subjective award, but deal-making acumen, management skills, and delivering shareholder value are important measuring sticks. It’s still too early to call this year’s contest, but Gline is a front-runner.

Last December, Roivant essentially acquired an experimental treatment for inflammatory bowel disease called RVT-3101 from Pfizer for $45 million and then spent another $5 million to position the drug for future Phase 3 studies. Less than a year later, Roivant flipped the drug to Roche for at least $7.1 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： 'Little Tech' descents on D.C., wanting a say in how AI is regulated

entertainment

WSS

Why Talkspace is targeting Medicare, a tricky market

STAT wants to know your pick for a great summer read or listen

A new initiative will help leaders fight the next pandemic

FDA approves Moderna’s RSV vaccine, its second licensed product

IVF doctors demand details after CooperSurgical lawsuit

Medicare drug price negotiation hearing pits pharma v Biden admin

leisure time

leisure time

entertainment

Hollywood unions extend contract negotiations for actors

Anthony Fauci pushes back on GOP claims during Covid hearing

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Why Talkspace is targeting Medicare, a tricky market

Continuity nursing helped my family in our darkest PICU moments

Pregnant women don't need prenatal multivitamins, study concludes

The cancer drug shortage isn’t new — and neither are the solutions

Biden's 'march

Guidelines to prevent youth baseball injuries need more muscle

FDA approves Moderna’s RSV vaccine, its second licensed product

entertainment

Senators tussle over abortion against the backdrop of a presidential campaign

Finland to offer bird flu vaccine to select groups of people, a possible global first

$1 billion proposal to grow Boston, Massachusetts biotech

Immune cells and nerve overgrowth may explain recurring UTI pain

Ancient Greek ideas underpin modern concepts of pregnancy

First over

hotspot

entertainment

focus

focus